Showing 1 - 7 results of 7 for search 'Thierry Passeron', query time: 0.05s Refine Results
  1. 1
    Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response

    Recurrence of metastatic Merkel carcinoma after cessation of avelumab in a patient previously with a complete response by Alexandra Picard‐Gauci, Laura Troin, Madleen Chassang, Thierry Passeron, Henri Montaudié

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study

    Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study by Thierry Passeron, Eric Fontas, Thierry Boye, Marie-Aleth Richard, Emmanuel Delaporte, Olivier Dereure

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Successful rechallenge with avelumab in a patient with advanced Merkel cell carcinoma who presented pembrolizumab‐induced myositis

    Successful rechallenge with avelumab in a patient with advanced Merkel cell carcinoma who presented pembrolizumab‐induced myositis by Clémence Bertold, Laura Troin, Madleen Chassang, Thierry Passeron, Jérôme Doyen, Henri Montaudié, Alexandra Picard‐Gauci

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    New Methodology to Evaluate Sunscreens Under Outdoor Conditions: A Double-Blind, Randomized Intra-Individual Clinical Study of a Water-Based Broad-Spectrum SPF50+ Versus SPF15 (P3) and SPF50+

    New Methodology to Evaluate Sunscreens Under Outdoor Conditions: A Double-Blind, Randomized Intra-Individual Clinical Study of a Water-Based Broad-Spectrum SPF50+ Versus SPF15 (P3)... by Corinne Granger, Jean Krutmann, Javier Bustos, Yolanda Sola, Muzzammil Hosenally, Carles Trullàs, Philippe Andres, Thierry Passeron

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of 0.05% ingenol mebutate in the treatment of basal cell carcinoma: A prospective study

    Efficacy and safety of 0.05% ingenol mebutate in the treatment of basal cell carcinoma: A prospective study by Marine Velin, Nathalie Cardot‐Leccia, Anne‐Claire Cathelineau, Luc Duteil, Catherine Queille‐Roussel, Thierry Passeron, Philippe Bahadoran

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial

    Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial by Alexa B. Kimball, Errol P. Prens, Thierry Passeron, Emanual Maverakis, Irina Turchin, Stefan Beeck, Leonidas Drogaris, Ziqian Geng, Tianyu Zhan, Izabella Messina, Falk G. Bechara

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Evaluating the Frequency of Mole Checks by a Dermatologist and Correlated Variables in a Global Survey across 17 Countries: HELIOS Project

    Evaluating the Frequency of Mole Checks by a Dermatologist and Correlated Variables in a Global Survey across 17 Countries: HELIOS Project by Henry William Lim, Thierry Passeron, Chee Leok Goh, Hee Young Kang, Fatimata Ly, Akimichi Morita, Jorge Ocampo-Candiani, Susana Puig, Sergio Schalka, Liu Wei, Anne Laure Demessant, Caroline Le Floc'h, Delphine Kerob, Brigitte Dreno, Jean Krutmann

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: